Evidence map›Paper›PMID 38889106›Full record

ArticlePloS one2024

A high-accuracy lightweight network model for X-ray image diagnosis: A case study of COVID detection.

Shujuan Wang, Jialin Ren, Xiaoli Guo

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shujuan WangCollege of Mathematics and Information Science, Zhengzhou University of Light Industry, Zhengzhou, China.ORCID 0000-0002-5505-0086
Jialin RenCollege of Mathematics and Information Science, Zhengzhou University of Light Industry, Zhengzhou, China.ORCID 0009-0002-2717-8389
Xiaoli GuoCollege of Mathematics and Information Science, Zhengzhou University of Light Industry, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Coronavirus Disease 2019(COVID-19) has caused widespread and significant harm globally. In order to address the urgent demand for a rapid and reliable diagnostic approach to mitigate transmission, the application of deep learning stands as a viable solution. The impracticality of many existing models is attributed to excessively large parameters, significantly limiting their utility. Additionally, the classification accuracy of the model with few parameters falls short of desirable levels. Motivated by this observation, the present study employs the lightweight network MobileNetV3 as the underlying architecture. This paper incorporates the dense block to capture intricate spatial information in images, as well as the transition layer designed to reduce the size and channel number of the feature map. Furthermore, this paper employs label smoothing loss to address the inter-class similarity effects and uses class weighting to tackle the problem of data imbalance. Additionally, this study applies the pruning technique to eliminate unnecessary structures and further reduce the number of parameters. As a result, this improved model achieves an impressive 98.71% accuracy on an openly accessible database, while utilizing only 5.94 million parameters. Compared to the previous method, this maximum improvement reaches 5.41%. Moreover, this research successfully reduces the parameter count by up to 24 times, showcasing the efficacy of our approach. This demonstrates the significant benefits in regions with limited availability of medical resources.

Indexed as

COVID-19Deep LearningAlgorithmsHumansImage Processing, Computer-AssistedNeural Networks, ComputerSARS-CoV-2

Identifiers

PMID38889106
PMCPMC11185471

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.